Boxer Capital as of Sept. 30, 2018
Portfolio Holdings for Boxer Capital
Boxer Capital holds 24 positions in its portfolio as reported in the September 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Solid Biosciences | 15.1 | $136M | 2.9M | 47.18 | |
Beigene (BGNE) | 12.0 | $109M | 630k | 172.22 | |
Ptc Therapeutics I (PTCT) | 11.2 | $101M | 2.2M | 47.00 | |
Wave Life Sciences (WVE) | 8.8 | $80M | 1.6M | 50.00 | |
Mirati Therapeutics | 8.2 | $74M | 1.6M | 47.10 | |
Esperion Therapeutics (ESPR) | 6.8 | $61M | 1.4M | 44.37 | |
Odonate Therapeutics Ord | 6.1 | $55M | 2.8M | 19.41 | |
Rocket Pharmaceuticals (RCKT) | 5.4 | $48M | 2.0M | 24.62 | |
Medicines Company | 4.7 | $42M | 1.4M | 29.91 | |
Dbv Technologies S A (DBVT) | 3.7 | $34M | 1.5M | 22.46 | |
Reata Pharmaceuticals Inc Cl A | 3.6 | $33M | 400k | 81.76 | |
Kiniksa Pharmaceuticals (KNSA) | 3.3 | $30M | 1.2M | 25.50 | |
Cymabay Therapeutics | 2.6 | $23M | 2.1M | 11.08 | |
Amarin Corporation (AMRN) | 2.4 | $21M | 1.3M | 16.27 | |
Kura Oncology (KURA) | 1.6 | $15M | 845k | 17.50 | |
Mei Pharma | 1.4 | $13M | 2.9M | 4.31 | |
Rigel Pharmaceuticals (RIGL) | 0.8 | $7.5M | 2.3M | 3.21 | |
Kalvista Pharmaceuticals (KALV) | 0.5 | $4.4M | 200k | 22.11 | |
Sunesis Pharmaceuticals Inc Ne | 0.5 | $4.3M | 2.1M | 2.00 | |
Regulus Therapeutics | 0.5 | $4.0M | 1.7M | 2.37 | |
Xenon Pharmaceuticals (XENE) | 0.4 | $4.0M | 300k | 13.20 | |
Bellerophon Therapeutics | 0.2 | $1.6M | 1.5M | 1.08 | |
Novus Therapeutics | 0.2 | $1.5M | 324k | 4.67 | |
Syndax Pharmaceuticals (SNDX) | 0.1 | $808k | 100k | 8.08 |